ArticleFrontiers in immunology2025

Case Report: Dual immunomodulatory and hematologic benefits of rituximab in refractory anemia of ANCA-associated vasculitis.

Ningjun Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.